Bellevue Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-65,864
| Closed | -$1.36M | – | 171 |
|
|
2022
Q4 | $1.36M | Sell |
65,864
-17,636
| -21% | -$365K | 0.02% | 132 |
|
|
2022
Q3 | $2.18M | Sell |
83,500
-6,600
| -7% | -$173K | 0.03% | 122 |
|
|
2022
Q2 | $2.28M | Sell |
90,100
-21,600
| -19% | -$547K | 0.03% | 126 |
|
|
2022
Q1 | $3.53M | Buy |
111,700
+24,200
| +28% | +$764K | 0.04% | 125 |
|
|
2021
Q4 | $3.54M | Sell |
87,500
-7,200
| -8% | -$291K | 0.04% | 132 |
|
|
2021
Q3 | $3.3M | Buy |
94,700
+19,700
| +26% | +$687K | 0.03% | 140 |
|
|
2021
Q2 | $2.06M | Hold |
75,000
| – | – | 0.02% | 141 |
|
|
2021
Q1 | $2.11M | Buy |
75,000
+24,000
| +47% | +$674K | 0.02% | 140 |
|
|
2020
Q4 | $1.32M | Buy |
+51,000
| New | +$1.32M | 0.02% | 152 |
|